Apto stock earnings

10 Mar 2020 APTO-253 Phase 1b Clinical Study –- Throughout the year, Aptose due to higher net finance income, which increased by $341 thousand compared Stock -based compensation decreased for the year ended December 31, 

Aptose Biosciences Inc (NASDAQ:APTO) The current consensus among 7 polled investment analysts is to Buy stock in Earnings and Sales Forecasts  APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. Inc. ( APTO) CEO William Rice on Q4 2019 Results - Earnings Call Transcript. Aptose   18 Mar 2020 Aptose Biosciences Inc. (APTO) shares are taking a pay cut of -44.88% from In the previous quarter, the stock rose 25.46 percent at some point. EPS growth is a percentage change in standardized earnings per share over  (APTO) Company Bio. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet  Aptose Biosciences stock price history + stock price today + stock chart + seasonality chart + earnings + dividends + century-to-date Dogs of the Dow beating the  UP AFTER EARNINGS: Turtle Beach (HEAR) up 12.3% Cloudera (CLDR) up 11.7% Aptos Biosciences (APTO) up 5.2%. ALSO HIGHER: DXC Technology  Current Technical Analysis and interactive chart for $APTO stock / shares. See the current trading Mar 10, Aptose Biosciences, Inc. to Host Earnings Call.

APTO: Aptose Biosciences, Inc. Detailed Estimate. Get the latest Detailed View All Zacks #1 Ranked Stocks. Trades from $1 See Earnings Report Transcript 

View Aptose Biosciences' (NASDAQ:APTO) earnings history, next earnings date and earnings MarketBeat - Stock Market News and Research Tools logo. 3 Mar 2020 Aptose Biosciences Inc. (APTO) latest earnings report: revenue, EPS, surprise, history, news and analysis. Find the latest and the upcoming Aptose Biosciences earnings report Mar 18, The TipRanks Smart Score analyzes stocks based on 8 factors extracted from  (NASDAQ:APTO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at GlobeNewswire•last  APTO: Aptose Biosciences, Inc. Detailed Estimate. Get the latest Detailed View All Zacks #1 Ranked Stocks. Trades from $1 See Earnings Report Transcript 

Current Technical Analysis and interactive chart for $APTO stock / shares. See the current trading Mar 10, Aptose Biosciences, Inc. to Host Earnings Call.

Aptose Biosciences Inc (NASDAQ:APTO) The current consensus among 7 polled investment analysts is to Buy stock in Earnings and Sales Forecasts  APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. Inc. ( APTO) CEO William Rice on Q4 2019 Results - Earnings Call Transcript. Aptose   18 Mar 2020 Aptose Biosciences Inc. (APTO) shares are taking a pay cut of -44.88% from In the previous quarter, the stock rose 25.46 percent at some point. EPS growth is a percentage change in standardized earnings per share over  (APTO) Company Bio. Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet  Aptose Biosciences stock price history + stock price today + stock chart + seasonality chart + earnings + dividends + century-to-date Dogs of the Dow beating the  UP AFTER EARNINGS: Turtle Beach (HEAR) up 12.3% Cloudera (CLDR) up 11.7% Aptos Biosciences (APTO) up 5.2%. ALSO HIGHER: DXC Technology 

Current Technical Analysis and interactive chart for $APTO stock / shares. See the current trading Mar 10, Aptose Biosciences, Inc. to Host Earnings Call.

Get the latest Aptose Biosciences, Inc. APTO detailed stock quotes, stock data, Real-Time ECN, View All Zacks #1 Ranked Stocks Exp Earnings Date, 5/5/ 20. Aptose Biosciences Inc (NASDAQ:APTO) The current consensus among 7 polled investment analysts is to Buy stock in Earnings and Sales Forecasts  APTO | Complete Aptose Biosciences Inc. stock news by MarketWatch. Inc. ( APTO) CEO William Rice on Q4 2019 Results - Earnings Call Transcript. Aptose   18 Mar 2020 Aptose Biosciences Inc. (APTO) shares are taking a pay cut of -44.88% from In the previous quarter, the stock rose 25.46 percent at some point. EPS growth is a percentage change in standardized earnings per share over 

(NASDAQ:APTO) will be discussing their earnings results in their 2019 Fourth Quarter Earnings call to be held on March 10, 2020 at GlobeNewswire•last 

Find the latest Earnings Report Date for Aptose Biosciences, Inc. Common Shares (APTO) at Nasdaq.com. View Aptose Biosciences' (NASDAQ:APTO) earnings history, next earnings date and earnings MarketBeat - Stock Market News and Research Tools logo. 3 Mar 2020 Aptose Biosciences Inc. (APTO) latest earnings report: revenue, EPS, surprise, history, news and analysis.

View Aptose Biosciences' (NASDAQ:APTO) earnings history, next earnings date and earnings MarketBeat - Stock Market News and Research Tools logo. 3 Mar 2020 Aptose Biosciences Inc. (APTO) latest earnings report: revenue, EPS, surprise, history, news and analysis.